Novavax gets FDA EUA for COVID-19 Vaccine, Adjuvanted as booster for adults
The FDA Emergency Use Authorisation decision was based on the findings of the phase 3 Prevent-19 clinical trial…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Oct 22
The FDA Emergency Use Authorisation decision was based on the findings of the phase 3 Prevent-19 clinical trial…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Oct 22
Under the long-term license agreement with WBCP, a series of innovative new flavors unites the epic excitement of…
19 Oct 22
The global market for CBD is expected to reach $4.09 billion by 2030 from $1.80 billion in 2021, registering impressive expansion at…
19 Oct 22
The proposed acquisition, valued at around $487m plus a contingent value right for up to $610m, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Oct 22
The South Korean company said that the acquisition will extend the commercial footprint of its life sciences division…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 Oct 22
MacroGenics will receive an upfront payment of $60m and is eligible to receive up to $1.7bn in potential…
18 Oct 22
Patients subjected to etripamil showed a statistically significant difference in time to conversion to PSVT, compared to placebo,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Oct 22
Boehringer Ingelheim is seeking approval in the European Union for its IL-36R inhibitor in generalised pustular psoriasis based…
17 Oct 22
The funding will help to generate new treatments and improve the delivery of healthcare services to support experimental…
14 Oct 22
The new financing will allow Odyssey Therapeutics to advance its portfolio of precision immunomodulators and oncology medicines, supporting…